Brief: Graybug Announces Pipeline Expansion, Current Cash Expected To Deliver Three Clinical Readouts In 2023

Calcimedica

30/03/2022 12:29

March 30 (Reuters) - Graybug Vision Inc  GRAY.O :
    * GRAYBUG ANNOUNCES PIPELINE EXPANSION, CURRENT CASH
EXPECTED TO
DELIVER THREE CLINICAL READOUTS IN 2023
    * GRAYBUG VISION INC - PHASE 2 TRIAL WITH OPTIMIZED
FORMULATION IN
WET AMD EXPECTED TO START IN Q4 OF 2022
    * GRAYBUG VISION INC - NEW PROGRAMS FOR RETINITIS PIGMENTOSA
AND
GEOGRAPHIC ATROPHY
    * GRAYBUG VISION INC - CURRENT CASH EXPECTED TO FUND PLANNED
OPERATIONS INTO Q4 OF 2023
    * GRAYBUG VISION INC - PHASE 1 TRIAL IN GLAUCOMA EXPECTED TO
COMMENCE IN Q1 OF 2023
    * GRAYBUG VISION INC - ACQUIRED CORNEAL GENE THERAPY
PROGRAM;
PHASE 1/2A DATA EXPECTED IN Q4 OF 2023

Source text for Eikon:  ID:nGNX3cbmc4 
Further company coverage:  GRAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))